Insider · CIK 0002011869
Peter Kaiser
Files at OCUL (OCULAR THERAPEUTIX, INC). First filing Nov 27, 2024, latest Oct 6, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OCUL: OCULAR THERAPEUTIX, INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 11Weak | OCULAR THERAPEUTIX, INC | $70k 9,990 shares | -4% | +1% from low-57% from high | |
| 10Weak | OCULAR THERAPEUTIX, INC | $23k 2,810 shares | -1% | +42% from low-48% from high | |
| 16Weak | OCULAR THERAPEUTIX, INC | $36k 3,007 shares | -2% | +104% from low-11% from high | |
| 20Weak | OCULAR THERAPEUTIX, INC | $106k 9,653 shares | -5% | +87% from low-19% from high | |
| 16Weak | OCULAR THERAPEUTIX, INC | $36k 3,011 shares | -1% | +100% from low-6% from high | |
| 10Weak | OCULAR THERAPEUTIX, INC | $21k 2,974 shares | -1% | +23% from low-36% from high | |
| 10Weak | OCULAR THERAPEUTIX, INC | $21k 3,009 shares | -1% | - | |
| 15Weak | OCULAR THERAPEUTIX, INC | $26k 2,897 shares | -1% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 24, 2025 | OCUL OCULAR THERAPEUTIX, INC. | 3,009 0.00% of outstanding | $21k | Feb 24, 2025 | $26k |
| Nov 25, 2024 | OCUL OCULAR THERAPEUTIX, INC. | 2,897 0.00% of outstanding | $26k | Nov 25, 2024 | none |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock10b5-1 | -9,990 | $7.05 | $70k | 254,388 | 7 d ago |
| Feb 23, 2026 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock10b5-1 | -2,810 | $8.28 | $23k | 269,108 | Feb 25, 2026 |
| Jan 2, 2026 | OCUL OCULAR THERAPEUTIX, INC | AGrant or award Common Stock | +79,112 | $0.00 | $0 | 271,918 | Jan 6, 2026 |
| Jan 2, 2026 | OCUL OCULAR THERAPEUTIX, INC | AGrant or award Stock Option (Right to Buy)derivative | +240,932 | $0.00 | $0 | 240,932 | Jan 6, 2026 |
| Nov 24, 2025 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock10b5-1 | -3,007 | $12.02 | $36k | 191,433 | Nov 26, 2025 |
| Oct 2, 2025 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock10b5-1 | -9,653 | $11.03 | $106k | 194,440 | Oct 6, 2025 |
| Aug 25, 2025 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock10b5-1 | -3,011 | $12.04 | $36k | 204,093 | Aug 27, 2025 |
| May 23, 2025 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock10b5-1 | -2,974 | $7.17 | $21k | 207,104 | May 27, 2025 |
| Feb 24, 2025 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock10b5-1 | -3,009 | $6.87 | $21k | 210,078 | Feb 26, 2025 |
| Nov 25, 2024 | OCUL OCULAR THERAPEUTIX, INC | SOpen-market sale Common Stock10b5-1 | -2,897 | $9.01 | $26k | 213,087 | Nov 27, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.